Company News in the Life Science Industry

ADELAIDE, Australia, June 3, 2020 /PRNewswire/ -- Toni Nesci has been appointed Head of Mayne Contract Services, a division of the Mayne Pharma family. Mayne Contract Services, based in Salisbury, South Australia is the full-service pharmaceutical development and manufacturing business unit created... Read more ››

FREIBURG, Germany, June 3, 2020 /PRNewswire/ -- Eleva, a manufacturer of superior biologics, is exploring the potential of one of its drug candidates for first-in-line therapy of COVID-19. The compound, factor H, is part of the complement system, which is believed to affect the severity of... Read more ››

SOUTH SAN FRANCISCO, Calif., June 2, 2020 /PRNewswire/ -- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis, today announced the pricing of its initial public offering of 9,000,000 shares of... Read more ››

SAN DIEGO, June 2, 2020 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM), a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, today announced the pricing of an underwritten... Read more ››

SUZHOU, China, June 2, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announces... Read more ››

SALZBURG, Austria, June 2, 2020 /PRNewswire/ -- As COVID-19 regulations ease, U.S.-based health technology company Electronic Caregiver® has developed a digital application to help professional soccer players in Austria resume training and competition as safely as possible.

- More than a third (36%) of regular exercisers are more active now than they were before lockdown

DUBLIN, June 2, 2020 /PRNewswire/ -- The Read more ››

SILVER SPRING, Md., June 2, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration today continued to take action in the ongoing response to the COVID-19 pandemic: